When the National Cancer Institute (NCI) removed all prostate-specific antigen (PSA) data from the Surveillance, Epidemiology, and End Results (SEER) and SEER-Medicare programs, it rendered many of ...
Large data sets like SEER need better quality control checks and researchers and clinicians who use these data sets should also consider using secondary data analyses that answer specific research ...
Analysis of the first subset of linked SEER patient data demonstrates DecisionDx®-Melanoma testing was associated with improved overall survival rates compared to untested patients DecisionDx-Melanoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback